Beauty Health Company (The) - Class A

NASDAQ: SKIN
$1.39
-$0.10 (-6.7%)
Closing Price on November 21, 2024

SKIN Stock Chart and Intraday Price

SKIN Stock Data

Asset Type Stock
Exchange NASDAQ
Currency USD
Country USA
Sector LIFE SCIENCES
Industry SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Address 2165 SPRING STREET, LONG BEACH, CA, US
Fiscal Year End December
Latest Quarter 9/30/2023
Market Cap 489.63M USD
Shares Outstanding 131,267,000
The Beauty Health Company, based in Long Beach, California, revolutionizes skincare through its innovative aesthetic technologies and products. Its flagship, HydraFacial, offers a unique three-step process to cleanse, extract, and hydrate the skin using specialized solutions and serums. Beyond HydraFacial, the company introduces Syndeo, a sophisticated delivery system, and the HydraFacial Nation App for personalized skin health tracking. Additionally, it offers Keravive, a specialized treatment focusing on scalp health, demonstrating its commitment to comprehensive beauty and wellness solutions since 1997.

SKIN Articles

Thursday's Top Analyst Upgrades and Downgrades: Adobe, Amazon, FedEx, Micron Technology, Peloton, Petrobras, Snowflake, Tesla, Victoria's Secret and More
Thursday's top analyst upgrades and downgrades included Adobe, Amazon.com, Avantor, Chipotle Mexican Grill, Coherent, FedEx, Infosys, Micron Technology, Peloton Interactive, Petrobras, Snowflake,...
Lee Jackson
Published:

Wednesday's Top Analyst Upgrades and Downgrades: Activision Blizzard, Alcoa, Amgen, BNY Mellon, Freeport-McMoRan, Kroger, Mattel, Valero Energy and More
Wednesday's top analyst upgrades and downgrades included Activision Blizzard, Alcoa, Amgen, Bank of New York Mellon, Boston Beer, Charles Schwab, Freeport-McMoRan, Kroger, Live Nation Entertainment,...
Lee Jackson
Published:

Wednesday's Top Analyst Upgrades and Downgrades: Alliance Data, AvalonBay, Boston Properties, Bruker, CBRE and More
Wednesday’s top analyst upgrades and downgrades included Alliance Data, AvalonBay, Boston Properties, Bruker, Camden Properties and CBRE.
Chris Lange
Published: